OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Role of diet in hyperuricemia and gout	80
The epidemiology of psoriatic arthritis: A literature review	58
Cardiac involvement in systemic sclerosis: Getting to the heart of the matter	44
Risk assessment tools for osteoporosis and fractures in 2022	41
The interplay between neutrophils, complement, and microthrombi in COVID-19	35
Clinical features of psoriatic arthritis	30
Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes	27
Managing patients using telerheumatology: Lessons from a pandemic	27
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc	25
Current status of imaging of Sjogren's syndrome	24
Modifiable risk factors for bone health & fragility fractures	23
Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions	23
Osteoporosis in 2022: Care gaps to screening and personalised medicine	21
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)	21
Muscle imaging in myositis: MRI, US, and PET	20
Current status of MR imaging of juvenile idiopathic arthritis	20
Contemporary imaging of rheumatoid arthritis: Clinical role of ultrasound and MRI	19
Pathogenesis of calcium pyrophosphate deposition disease	19
Risk factors for osteoporosis and fractures in rheumatoid arthritis	18
Botulinum toxin in the management of primary and secondary Raynaud's phenomenon	18
Imaging in the diagnosis and management of peripheral psoriatic arthritis	18
The burden of osteoarthritis: Is it a rising problem?	18
Treatment advances in gout	18
Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications	17
The role of calcium crystals and their effect on osteoarthritis pathogenesis	16

Pathogenesis of psoriatic arthritis	16
Treating-to-target in rheumatology: Theory and practice	16
Imaging in large-vessel vasculitis	16
Nailfold capillaroscopy	16
Ultrasound imaging in paediatric rheumatology	16
Urate transport in health and disease	14
Calcium pyrophosphate deposition (CPPD) disease – Treatment options	14
Unmet needs in psoriatic arthritis	14
The microbiome and systemic sclerosis: A review of current evidence	14
Pre-RA: Can early diagnosis lead to prevention?	13
Diagnosis, classification, and assessment in psoriatic arthritis	13
The global burden of fragility fractures – what are the differences, and where are the gaps	13
The genetic basis of urate control and gout: Insights into molecular pathogenesis from follow-up study of genome-wide association study loci	13
Osteoporosis in children and young adults	13
Precision medicine in rheumatoid arthritis	12
Employment outcomes in systemic sclerosis	12
Autoantibodies: Pathogenic or epiphenomenon	12
Treatment of rheumatic adverse events of cancer immunotherapy	12
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues	11
Management of interstitial lung disease (ILD) in myositis syndromes: A practical guide for clinicians	11
Imaging in the diagnosis and management of axial spondyloarthritis in children	11
Change of the microvascularization in systemic sclerosis, a matter of air	11
Osteoarthritis today: Lost in translation?	11
A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis	11
Is it really myositis? Mimics and pitfalls	10
Management of Takayasu arteritis	10
Imaging in psoriatic arthritis: Status and recent advances	10
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	10
Cardiovascular disease and depression in psoriatic arthritis: Multidimensional comorbidities requiring multidisciplinary management	10
The protective effect of rheumatic disease agents in COVID-19	10
Risk for osteoporosis and fracture with glucocorticoids	10
Computed tomography in rheumatology – From DECT to high-resolution peripheral quantitative CT	9
The role of imaging in osteoarthritis	9
Infectious mimics of rheumatoid arthritis	9
Systemic lupus erythematosus	8
Current treatments and recommendations for Psoriatic Arthritis	8
Vascular ultrasound in rheumatology practice	8
Update of imaging in the diagnosis and management of axial spondyloarthritis	8
Impaired bone health as a co-morbidity of epilepsy	8
Possible future avenues for myositis therapeutics: DM, IMNM and IBM	8
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?	7
Review: Outcome measures in calcium pyrophosphate deposition	7
Review for best practice in clinical rheumatology juvenile systemic sclerosis – Updates and practice points	7
Imaging of crystalline arthropathy in 2020	7
Male osteoporosis-what are the causes, diagnostic challenges, and management	7
Treatment overview of axial spondyloarthritis in 2023	7
Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis	7
Pathophysiology and immunolgical basis of axial spondyloarthritis	7
Rheumatoid arthritis: Evolving recognition of a common disease	7
Cancer and myositis: Who, when, and how to screen	7

Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunity	7
Biomarkers for osteoarthritis: Current status and future prospects	7
What is new in pharmacological treatment for osteoarthritis?	6
Diagnostic delay in axial spondylarthritis: A lost battle?	6
Recent advances in the treatment of giant cell arteritis	6
Clinical aspects and outcomes in osteoarthritis	6
Imaging of OA – From disease modification to clinical utility	6
Reframing health disparities in SLE: A critical reassessment of racial and ethnic differences in lupus disease outcomes	6
Synovial fluid analysis: Relevance for daily clinical practice	6
Enhancing patient research partner engagement: Research in psoriatic arthritis	5
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	5
COVID-19 pandemic management and the rheumatology patient	5
Clinical and molecular significance of genetic loci associated with psoriatic arthritis	5
Classification and epidemiology of vasculitis: Emerging concepts	5
Challenges in the diagnosis of axial spondyloarthritis	5
Pain in osteoarthritis from a symptom to a disease	5
When are patients with osteoarthritis referred for surgery?	5
Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain?	5
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	5
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	5
Cardiovascular risk in vasculitis	5
Seeing is believing: Smart use of musculoskeletal ultrasound in rheumatology practice	4
Impact of sex and gender on axSpA diagnosis and outcomes	4
Muscle biopsy in myositis: What the rheumatologist needs to know	4
Novel therapies and innovation for systemic sclerosis skin ulceration	4
Pregnancy in systemic lupus erythematosus	4
Deficiency of adenosine deaminase 2 (DADA2): Review	4
Antifibrotics in systemic sclerosis	4
Musculoskeletal manifestations of systemic lupus erythematosus	4
Functional capacity, sarcopenia, and bone health	3
The racial/ethnic and sociocultural aspects of the pandemic in rheumatology	3
The challenge of gout flare measurement	3
Regenerative methods in osteoarthritis	3
Systemic lupus erythematosus and damage: What has changed over the past 20 years?	3
Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic	3
VEXAS syndrome, a new kid on the block of auto-inflammatory diseases: A hematologist's point of view	3
Current evidence and practical knowledge for ultrasound-guided procedures in rheumatology: Joint aspiration, injection, and other applications	3
Assessment of disease activity and damage in SLE: Are we there yet?	3
“Fibromyalgia – are there any new approaches?”	3
Implications of a diagnosis of rheumatoid arthritis in resource-poor countries	3
Imaging of giant cell arteritis – recent advances	3
Relapsing polychondritis: Best Practice & Clinical Rheumatology	3
Pregnancy & neonatal outcomes in spondyloarthritis	2
The association between comorbidities and disease activity in spondyloarthritis – A narrative review	2
Where is bone science taking us?	2
Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions	2
Clinical patterns of disease: From early systemic lupus erythematosus to late-onset disease	2
How to implement guidelines and models of care	2
New and future therapies: Changes in the therapeutic armamentarium for SLE	2
Advanced molecular imaging in large-vessel vasculitis: Adopting FDG-PET into a clinical workflow	2
Idiopathic inflammatory myopathies: Progress, challenges, and future perspectives	2
Myofascial pain – A major player in musculoskeletal pain	2
Psoriatic Arthritis: Current status	2
Rehabilitation interventions in osteoarthritis	2
Practical approaches for clinicians in chronic pain management: Strategies and solutions	2
Recent targets of osteoarthritis research	2
Best practices for ultrasound-guided synovial biopsy in the United States	2
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis	2
Novel therapies in axial spondyloarthritis	2